Investigation Overview
An investigation on behalf of current investors in Dialysis Corporation of America (NASDAQ:DCAI) concerning shareholder claims over possible breaches of fiduciary duty by the board of directors of Dialysis Corporation of America was announced The investigation by law firm focuses on potential breaches of fiduciary duty and other violations of state law by the Board of Directors of Di...
You must register (for free) or login to view the entire investigation.